Sarcoma, Kaposi

AQ = BL BS CF CH CI CL CN CO DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RA RH RI RT SC SE SU TH UL UR US VE VI
PRINT ENTRY = Kaposi Sarcoma|T191|EPO|EQV|UNK (19XX)|740330|abcdef
ENTRY = Kaposi's Sarcoma|T191|EPO|EQV|NLM (1998)|960927|abcdef
ENTRY = Kaposis Sarcoma
ENTRY = Sarcoma, Kaposi's
MN = C02.256.466.860
MN = C04.557.450.795.850
MN = C04.557.645.750
MH_TH = NLM (1966)
ST = T191
AN = /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term (IM)
MS = A multicentric, malignant neoplastic vascular proliferation characterized by the development of bluish-red cutaneous nodules, usually on the lower extremities, most often on the toes or feet, and slowly increasing in size and number and spreading to more proximal areas. The tumors have endothelium-lined channels and vascular spaces admixed with variably sized aggregates of spindle-shaped cells, and often remain confined to the skin and subcutaneous tissue, but widespread visceral involvement may occur. Kaposi's sarcoma occurs spontaneously in Jewish and Italian males in Europe and the United States. An aggressive variant in young children is endemic in some areas of Africa. A third form occurs in about 0.04% of kidney transplant patients. There is also a high incidence in AIDS patients. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, pp2105-7) HHV-8 is the suspected cause.
PM = 98; was SARCOMA, KAPOSI'S 1963-97; KAPOSI SARCOMA was KAPOSI'S SARCOMA 1963-97
HN = 98; was SARCOMA, KAPOSI'S 1963-97; KAPOSI SARCOMA was KAPOSI'S SARCOMA 1963-97
MED = *696
MED = 898
M90 = *734
M90 = 1059
M85 = *817
M85 = 1327
M80 = *469
M80 = 708
M75 = *152
M75 = 204
M66 = *237
M66 = 330
M94 = *886
M94 = 1216 CATSH = CAT LIST
MR = 19970620
DA = 19990101
DC = 1
UI = D012514